Catalyst Wire Dossier Catalyst Wire Dossier

Anti-IGF-1R antibodies

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-IGF-1R antibodies, covering 2018-07-30 to 2018-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy

See pricing